Specialty Pharmacy

Combination therapy found to increase anti-tumor activity among patients with metastatic colorectal cancer.

Joy Gilbert, Vice President, Operations, US Bioservices, a part of AmerisourceBergen, discusses the importance of new orphan drug approvals for patients.

T cell alterations could exacerbate acute hepatitis infections.

Lutetium Lu 177 dotate (Luthathera) approved to treat gastroenteropancreatic neuroendocrine tumors.

Top news of the day from across the health care landscape.

Identifying current deficiencies in clinical practice can help pinpoint care practices that can be implemented for cancer survivors.

Matt Gillin, Chief Executive Officer, Relay Network, talks about why mobile health is important for patient care.

An enzyme may play a crucial role in exposing melanoma cells to immune system attack.

Data are limited regarding the safety and efficacy of antiretroviral therapy in pregnant women.

A look at last week's top stories in the world of pharmacy.

HIV reservoirs are resistant to CD8+ T-cells, which eliminate infected cells.

Top news of the week from Specialty Pharmacy Times.

Many factors influence whether a specialty pharmacy can gain access to limited distribution drug networks.

T-cells modified to express dominant-negative TGF-β receptor type 2 overcame cancer cell defenses.

An immunomodulatory cytokine interacts with its receptors differently than other cytokines.

An obesity drug may reduce the risk of metastatic prostate cancer.

Top news of the day from across the health care landscape.

FDA seeks to change policies to ensure balance between the need to preserve access and ensure safety of appropriately compounded drugs for patients whose needs cannot be met by FDA-approved products.

Erenumab observed to reduce monthly migraine days.

Amanda Walker, CPXP, BSN, RN, Senior Vice President, Patient Experience, Heritage Biologics, discusses RXPX, the Pharmacy Patient Experience Certification.

Gene expression may lead to castration-resistant prostate cancer.

A multiple sclerosis drug may be used as a PET scan tracer agent to image demyelination.

Top news of the day from across the health care landscape.

Patients with both hepatitis C and type 2 diabetes can develop fibrosis, steatosis, hepatocellular carcinoma, and resistance to antiviral treatment.

Vector-based gene therapy shows efficacy treating glaucoma.

Sen Bill Cassidy, MD (R-LA), proposes legislation that would require hospitals to pass 340B savings on to patients.

Court invalidates patent for abiraterone acetate (Zytiga).

Limited access to gene therapies may impact Americans with rare cancers who live in rural areas.